These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10434400)

  • 1. Studies on disease-modifying antirheumatic drugs. IV. Synthesis of novel thieno[2,3-b:5,4-c']dipyridine derivatives and their anti-inflammatory effect.
    Baba A; Mori A; Yasuma T; Unno S; Makino H; Sohda T
    Chem Pharm Bull (Tokyo); 1999 Jul; 47(7):993-9. PubMed ID: 10434400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on disease-modifying antirheumatic drugs: synthesis of novel quinoline and quinazoline derivatives and their anti-inflammatory effect.
    Baba A; Kawamura N; Makino H; Ohta Y; Taketomi S; Sohda T
    J Med Chem; 1996 Dec; 39(26):5176-82. PubMed ID: 8978845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on disease-modifying antirheumatic drugs. II. Synthesis and activity of the metabolites of ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quino line-3-carboxylate (TAK-603).
    Baba A; Makino H; Ohta Y; Sohda T
    Chem Pharm Bull (Tokyo); 1998 Jul; 46(7):1130-4. PubMed ID: 9692219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on disease-modifying antirheumatic drugs. III. Bone resorption inhibitory effects of ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl) quinoline-3-carboxylate (TAK-603) and related compounds.
    Baba A; Oda T; Taketomi S; Notoya K; Nishimura A; Makino H; Sohda T
    Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):369-74. PubMed ID: 10212387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of disease causative T-cells in experimental autoimmune disease models by a new antirheumatic drug, TAK-603.
    Ohta Y; Fukuda S; Makino H
    Immunopharmacology; 1997 Oct; 37(2-3):167-74. PubMed ID: 9403335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulating and articular protecting activities of a new anti-rheumatic drug, TAK-603.
    Ohta Y; Fukuda S; Baba A; Nagai H; Tsukuda R; Sohda T; Makino H
    Immunopharmacology; 1996 Aug; 34(1):17-26. PubMed ID: 8880222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis.
    Revesz L; Blum E; Di Padova FE; Buhl T; Feifel R; Gram H; Hiestand P; Manning U; Rucklin G
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3595-9. PubMed ID: 15177482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent.
    Miwatashi S; Arikawa Y; Kotani E; Miyamoto M; Naruo K; Kimura H; Tanaka T; Asahi S; Ohkawa S
    J Med Chem; 2005 Sep; 48(19):5966-79. PubMed ID: 16162000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and inhibitory effect of threo-DL-phenyl-serine derivatives in rat experimental adjuvant arthritis model.
    Dirvianskyte N; Leonaviciené L; Butkus E
    Pharmazie; 2002 Sep; 57(9):650-1. PubMed ID: 12369458
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel DMARDs on the basis of a new concept of dual cytokine regulation, TNF-alpha suppression and IL-10 augmentation.
    Hanano T; Adachi K; Aoki Y; Morimoto H; Naka Y; Hisadome M; Fukuda T; Sumichika H
    Bioorg Med Chem Lett; 2000 May; 10(9):881-4. PubMed ID: 10853651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of 4-amino-2, 3-diaryl-5, 6, 7, 8-tetrahydrofuro(and thieno)[2, 3-b]-quinolines, and 4-amino-5, 6, 7, 8, 9-pentahydro-2, 3-diphenylcyclohepta[e]furo(and thieno)-[2, 3-b]pyridines.
    Marco JL; De Los Ríos C; Carreiras MC; Baños JE; Badia A; Vivas NM
    Arch Pharm (Weinheim); 2002 Jul; 335(7):347-53. PubMed ID: 12207285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and cytotoxicity of thieno[2,3-b]quinoline-2-carboxamide and cycloalkyl[b]thieno[3,2-e]pyridine-2-carboxamide derivatives.
    Leung E; Pilkington LI; van Rensburg M; Jeon CY; Song M; Arabshahi HJ; De Zoysa GH; Sarojini V; Denny WA; Reynisson J; Barker D
    Bioorg Med Chem; 2016 Mar; 24(5):1142-54. PubMed ID: 26853836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats.
    Yamamoto N; Sakai F; Yamazaki H; Kawai Y; Nakahara K; Okuhara M
    J Rheumatol; 1996 Oct; 23(10):1778-83. PubMed ID: 8895158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAK-603, new rheumatic drug, inhibits rat mixed lymphocyte reactions and prolonges rat skin allograft survival.
    Fujita T; Ezoe K; Matsumoto Y; Saito T; Homma K; Jimbow K; Sato N
    Transplant Proc; 2002 Jun; 34(4):1133-5. PubMed ID: 12072297
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synthesis and pharmacological activity of 1,2,3-triazole derivatives of naphthalene, quinoline and pyridine].
    Livi O; Ferrarini PL; Tonetti I; Smaldone F; Zefola G
    Farmaco Sci; 1979 Mar; 34(3):217-28. PubMed ID: 230987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of 5-phenylthiophenecarboxylic acid derivatives as antirheumatic agents.
    Noguchi T; Hasegawa M; Tomisawa K; Mitsukuchi M
    Bioorg Med Chem; 2003 Nov; 11(22):4729-42. PubMed ID: 14556788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAK-603 selectively suppresses Th1-type cytokine production and inhibits the progression of adjuvant arthritis.
    Ohta Y; Yamane M; Sohda T; Makino H
    Immunology; 1997 Sep; 92(1):75-83. PubMed ID: 9370927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antirheumatic agents. I. Novel methotrexate derivatives bearing an indoline moiety.
    Matsuoka H; Kato N; Tsuji K; Maruyama N; Suzuki H; Mihara M; Takeda Y; Yano K
    Chem Pharm Bull (Tokyo); 1996 Jul; 44(7):1332-7. PubMed ID: 8706140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiproliferative activity of 2-chlorophenyl carboxamide thienopyridines.
    van Rensburg M; Leung E; Haverkate NA; Eurtivong C; Pilkington LI; Reynisson J; Barker D
    Bioorg Med Chem Lett; 2017 Jan; 27(2):135-138. PubMed ID: 27979592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling, enzyme activity, anti-inflammatory and antiarthritic activities of newly synthesized quinazoline derivatives.
    Abuelizz HA; Hassane AE; Marzouk M; Ezzeldin E; Ali AA; Al-Salahi R
    Future Med Chem; 2017 Nov; 9(17):1995-2009. PubMed ID: 28789563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.